Rankings
▼
Calendar
PHIO Q1 2025 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-41070.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$43,000
Balance Sheet
Total Assets
$13M
Total Liabilities
$1M
Stockholders' Equity
$12M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$2M
-$2M
+15.3%
Net Income
-$2M
-$2M
+17.9%
← FY 2025
All Quarters
Q2 2025 →